Safety Recommendations for Administering Intravenous Prostacyclins in the Hospital.
Prostacyclins are a high-risk category of continuous intravenous infusions increasingly used in hospitals to treat advanced pulmonary arterial hypertension, a rare condition characterized by vasoconstriction and vascular proliferation of the pulmonary arteries. Prostacyclins are given in doses of na...
| Publicado en: | Critical Care Nurse Vol. 33; no. 5; pp. 32 - 42 |
|---|---|
| Autores principales: | , |
| Formato: | CEU exam questions tables/charts teaching materials Journal Article |
| Publicado: |
American Association of Critical-Care Nurses
Oct2013
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Sumario: | Prostacyclins are a high-risk category of continuous intravenous infusions increasingly used in hospitals to treat advanced pulmonary arterial hypertension, a rare condition characterized by vasoconstriction and vascular proliferation of the pulmonary arteries. Prostacyclins are given in doses of nanograms per kilogram per minute and have a narrow therapeutic dosing range for each patient. Sudden increases or decreases in dose can be life threatening. Previous studies revealed errors in the administration of these high-risk infusions, which in some instances led to serious adverse events, including death. The literature was reviewed for safety measures in administration of high-risk intravenous medications and input was obtained from leading experts in pulmonary arterial hypertension to create a set of safety recommendations for infusion of prostacyclins. |
|---|